Market revenue in 2023 | USD 241.5 million |
Market revenue in 2030 | USD 370.0 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50.43% in 2023. Horizon Databook has segmented the Spain interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The growing burden of coronary heart diseases, stroke, drives the demand for interventional cardiology in Spain. In August 2022, as per an article published in Taylor & Francis Online, there were around 814,470 patients with ischemic heart disease, 71% of them being males, along with hypertension, hypercholesterolemia, diabetes mellitus, and tobacco use, among others, as related comorbidities.
Therefore, Spain is facing a growing incidence of CVDs, which is fueling the market growth.In Spain, the National Health System (NHS) covers the cost of interventional cardiology devices through the Public Health System (Sistema Nacional de Salud).
The Ministry of Health, Social Services, and Equality (Ministerio de Sanidad, Servicios Sociales e Igualdad) and the National Institute for Health and Clinical Excellence provide guidance on reimbursement policies for medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Spain interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account